Boston Scientific Corporation reported that it plans to eliminate up to 1,000 jobs globally through attrition and targeted head count reductions as part of an expanded restructuring intended to get the medical device company's financial house in order. Boston Scientific reported that its board approved the expanded restructuring January 25, 2013 as a means to further strengthen the company's operational effectiveness and efficiencies and support new investments. The expanded restructuring is anticipated to reduce the company's pretax operating expenses by between $100 million to $115 million in 2013, bringing Boston Scientific's savings through the total restructuring to between $340 million and $375 million next year.

Much of those savings will come through job cuts. Boston Scientific reported the expanded restructuring will likely reduce its payroll by 900 to 1,000 positions. The move will essentially double the number of job cuts originally planned through the company's restructuring first announced in 2011, bringing the cut's total tally to between 2,100 and 2,400 positions.

The company announced that the job reductions will occur throughout its global footprint. It did not identify specific markets or positions to be eliminated.